Related parties

3 Months Ended

Nov. 30, 2020

The Company has a long-term pharmaceutical distribution agreement with AmerisourceBergen pursuant to which the Company sources branded and generic pharmaceutical products from AmerisourceBergen principally for its U.S. operations. Additionally, AmerisourceBergen receives sourcing services for generic pharmaceutical products.

Related party transactions with AmerisourceBergen (in millions):


	Three months ended November 30,
		2020		2019
Purchases, net		$	15,441	$	14,476


	November 30, 2020		August 31, 2020
Trade accounts payable, net	$	6,753	$	6,390